CRO’s are looking for a proven platform- so they don’t have to spend time and money to build.
Hybrid decentralized clinical trials model ideal for
Phase III and Phase IV post-marketing trials.
Ideal for long term observational trials.
- Ideal for Survivability visits.
- Ideal for Outcome trials.
- Ideal for rare disease indications.
- Ideal for centralized ratings-CNS trials.